Study of Mental Care in Spain

This study is currently recruiting participants.

Verified by AstraZeneca, April 2009

First Received: January 15, 2009 Last Updated: April 21, 2009 History of Changes

Sponsored by:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00824031

Purpose

Non-interventional, multicenter, cross-sectional study to evaluate the mental care received by schizophrenic patients and their caregivers in Spain irrespective of the drug prescribed.

Condition
Schizophrenia

MedlinePlus related topics: Caregivers Schizophrenia

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cross-Sectional
Official Title:	Study of Mental Care in Spain

Further study details as provided by AstraZeneca:

Primary Outcome Measures:

Camberwell's scale of Needs Analysis (CAN) [ Time Frame: Once ] [ Designated as safety issue: No ]
Caregiver Needs Questionnaire(CNF) [ Time Frame: Once ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Health of the Nation Outcome Scales (HoNOS) [ Time Frame: Once ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	150
Study Start Date:	April 2009
Estimated Study Completion Date:	June 2009

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patient aged 18-year old or older who has been diagnosed as schizophrenia

Criteria

Inclusion Criteria:

Schizophrenia (DSM-IV criteria)
Attended to the mental care units for the first time in 2006

Exclusion Criteria:

Participation in another clinical trial
Other criteria that according to the medical criteria make difficult the normal development of the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00824031

Contacts

Contact: AstraZeneca Spain Clinical Study Information

+34 913019243

esteban.medina@astrazeneca.com

Locations

Spain
Research Site	Recruiting
Cordoba, Spain
Research Site	Recruiting
Girona, Spain
Research Site	Recruiting
Madrid, Spain
Spain, A Coruna
Research Site	Recruiting
Ferrol, A Coruna, Spain
Spain, Asturias
Research Site	Recruiting
Aviles, Asturias, Spain
Spain, Cadiz
Research Site	Recruiting
Jerez de la Frontera, Cadiz, Spain
Spain, Castellon
Research Site	Recruiting
Torrejon de Ardoz, Castellon, Spain
Spain, Valencia
Research Site	Recruiting
La Plana, Valencia, Spain
Spain, Vizcaya
Research Site	Recruiting
Bilbao, Vizcaya, Spain

Sponsors and Collaborators

AstraZeneca

Investigators

Study Chair:	Manuel Gomez-Beneyto	University of Valencia
Study Chair:	Alberto Gonzalez	Hospital Universitario Principe de Asturias

More Information

No publications provided

Responsible Party:	AstraZeneca Pharmaceutical ( Esteban Medina. Epidemiology Specialist )
Study ID Numbers:	NIS-NES-DUM-2008/4
Study First Received:	January 15, 2009
Last Updated:	April 21, 2009
ClinicalTrials.gov Identifier:	NCT00824031 History of Changes
Health Authority:	Spain: Comité Ético de Investigación Clínica

Keywords provided by AstraZeneca:

schizophrenia
medical mental care
caregiver
Sapin

Study placed in the following topic categories:

Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

Additional relevant MeSH terms:

Schizophrenia
Mental Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on May 07, 2009